Analysts Viewpoint Investing in AIM ImmunoTech Inc (AIM): What You Must Know AIM ImmunoTech Inc’s recently made public that its CEO & President Equels Thomas K acquired Company’s shares for reported $25000.0
Stock Earnings A Guide To The Risks Of Investing In AIM ImmunoTech Inc (AIM) AIM ImmunoTech Inc’s recent filing unveils that its CEO & President Equels Thomas K acquired Company’s shares for reported $25000.0
Analysts Viewpoint A Guide To The Risks Of Investing In AIM ImmunoTech Inc (AIM) AIM ImmunoTech Inc’s recently made public that its Director BRYAN NANCY acquired Company’s shares for reported $15000.0 on Mar 21
Insiders Updates Negative sentiment towards AIM reflected by a jump of 16.34% in short interest Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its